CLINICAL_TRIALS
trial_result
· 2021-01-07
Clinical Trial Update: Study to Evaluate the Effect of Voxelotor Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE) [Phase 3]
Summary
Phase 3 clinical trial update for voxelotor in sickle cell disease has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Sickle Cell Disease | Phase 3 | Status: COMPLETED | Results posted: 2021-01-07